
Sign up to save your podcasts
Or


Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
By John Simboli5
77 ratings
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.

3,075 Listeners

1,967 Listeners

1,093 Listeners

2,354 Listeners

948 Listeners

797 Listeners

124 Listeners

337 Listeners

6,089 Listeners

92 Listeners

10,182 Listeners

576 Listeners

149 Listeners

248 Listeners

188 Listeners